# Randomized Comparison of Abciximab Plus Heparin With Bivalirudin in Acute Coronary Syndrome

> **NCT00373451** · PHASE4 · COMPLETED · sponsor: **Deutsches Herzzentrum Muenchen** · enrollment: 1721 (actual)

## Conditions studied

- Myocardial Infarction
- Coronary Disease

## Interventions

- **DRUG:** Abciximab + UFH
- **DRUG:** Bivalirudin
- **DRUG:** Heparin

## Key facts

- **NCT ID:** NCT00373451
- **Lead sponsor:** Deutsches Herzzentrum Muenchen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2011-05
- **Final completion:** 2011-07
- **Target enrollment:** 1721 (ACTUAL)
- **Last updated:** 2012-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00373451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00373451, "Randomized Comparison of Abciximab Plus Heparin With Bivalirudin in Acute Coronary Syndrome". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT00373451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*